The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRH Regulatory News (CRH)

Share Price Information for CRH (CRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,314.00
Bid: 6,316.00
Ask: 6,318.00
Change: -18.00 (-0.28%)
Spread: 2.00 (0.032%)
Open: 6,298.00
High: 6,322.00
Low: 6,286.00
Prev. Close: 6,332.00
CRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CRH establishes Euro Commercial Paper Programme

31 Jul 2017 07:00

RNS Number : 4993M
CRH PLC
31 July 2017
 

NOT FOR RELEASE OR DISTRIBUTION IN OR INTO THE UNITED STATES

 

Press Release

CRH plc establishes €1.5 Billion

Euro Commercial Paper Programme

 

31 July 2017

 

CRH plc, the international building materials group, is pleased to announce that it has established a euro commercial paper programme ("CRH ECP Programme"). Under the CRH ECP Programme, CRH Finance DAC and CRH Finance (U.K.) plc, wholly-owned finance subsidiaries of CRH plc, may issue, from time to time (together, the "Issuers"), unsecured short-term euro commercial paper notes (the "Notes") through appointed dealers up to a maximum aggregate amount outstanding at any time of €1.5 billion. The Notes will be guaranteed by CRH plc (the "Guarantor") and will be sold to investors outside the US. The CRH ECP Programme adds flexibility to CRH's short-term funding options, and complements CRH's US commercial paper program launched in 2016.

 

The CRH ECP Programme has been assigned short-term ratings of A-2+ by Standard & Poor's Credit Market Services Europe Limited ("S&P"), Prime-2 ("P-2") by Moody's Deutschland GmbH ("Moody's") and F2 by Fitch Ratings Ltd ("Fitch").

 

****

 

Contact CRH at Dublin 404 1000 (+353 1 404 1000)

 

Frank Heisterkamp Head of Investor Relations

 

 

About CRH

CRH (LSE: CRH, ISE: CRG, NYSE: CRH) is a leading global diversified building materials group, employing c.87,000 people at c.3,800 operating locations in 31 countries worldwide. With a market capitalisation of c.€26 billion (July 2017), CRH is the largest building materials company in North America and the second largest worldwide. The Group has leadership positions in Europe as well as established strategic positions in the emerging economic regions of Asia and South America. CRH is committed to improving the built environment through the delivery of superior materials and products for the construction and maintenance of infrastructure, housing and commercial projects. A Fortune 500 company, CRH is a constituent member of the FTSE 100 index, the EURO STOXX 50 index and the ISEQ 20. CRH's American Depositary Shares are listed on the NYSE. For more information visit www.crh.com 

 

****

 

Nothing in this announcement constitutes an offer of securities for sale in the United States or any other jurisdiction where it is unlawful to do so. The Notes have not been, and will not be, registered under the Securities Act of 1933 or any relevant securities laws of any state or other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act of 1933. The Notes constitute commercial paper for the purposes of, and are issued in accordance with an exemption granted by the Central Bank of Ireland under, Section 8(2) of the Central Bank Act, 1971 of Ireland, inserted by Section 31 of the Central Bank Act, 1989 of Ireland, as amended by Section 70(d) of the Central Bank Act, 1997 of Ireland each as amended by the Central Bank and Financial Services Authority of Ireland Act 2004.

 

No application will be made at any time to list the Notes on any stock exchange. A communication of an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the "FSMA")) received in connection with the issue or sale of any Notes will only be made in circumstances in which Section 21(1) of the FSMA does not apply to the Issuers or the Guarantor.

 

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSRDVITFID
Date   Source Headline
30th Apr 20249:30 amRNSTransaction in Own Shares
29th Apr 20249:30 amRNSTransaction in Own Shares
25th Apr 20245:00 pmRNSDirector/PDMR Shareholding
25th Apr 20244:30 pmRNSAGM Statement
25th Apr 20248:30 amRNSTransaction in Own Shares
4th Apr 20244:15 pmRNSTransaction in Own Shares
2nd Apr 20244:10 pmRNSBlock listing Interim Review
2nd Apr 20243:08 pmRNSTotal Voting Rights
27th Mar 20245:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:30 pmRNSDirector/PDMR Shareholding
20th Mar 20249:30 amRNSTransaction in Own Shares
19th Mar 20249:40 amRNSTransaction in Own Shares
19th Mar 20249:15 amRNSTransaction in Own Shares
15th Mar 20243:15 pmRNSNotice of AGM
15th Mar 20249:30 amRNSTransaction in Own Shares
14th Mar 20249:30 amRNSTransaction in Own Shares
13th Mar 20249:30 amRNSTransaction in Own Shares
12th Mar 20249:15 amRNSTransaction in Own Shares
11th Mar 20249:30 amRNSTransaction in Own Shares
8th Mar 20245:00 pmRNSDirector/PDMR Shareholding
8th Mar 20249:30 amRNSTransaction in Own Shares
7th Mar 20249:30 amRNSTransaction in Own Shares
6th Mar 20248:45 amRNSTransaction in Own Shares
5th Mar 20245:30 pmRNSDirector/PDMR Shareholding
5th Mar 20249:45 amRNSTransaction in Own Shares
4th Mar 20244:00 pmRNSTransaction in Own Shares
4th Mar 20249:45 amRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSTransaction in Own Shares
29th Feb 20243:00 pmRNSTotal Voting Rights
29th Feb 202412:05 pmRNS2023 Annual Report on Form 10-K
29th Feb 20248:45 amRNSTransaction in Own Shares
28th Feb 20249:30 amRNSTransaction in Own Shares
27th Feb 20249:30 amRNSTransaction in Own Shares
26th Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20247:05 amRNS5% Preference Shares - Listings Update
22nd Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20247:05 amRNS5% Preference Shares - Listings Update
19th Feb 20249:30 amRNSTransaction in Own Shares
16th Feb 20249:30 amRNSTransaction in Own Shares
15th Feb 20249:30 amRNSTransaction in Own Shares
14th Feb 20249:30 amRNSTransaction in Own Shares
9th Feb 20249:30 amRNSTransaction in Own Shares
8th Feb 20249:30 amRNSTransaction in Own Shares
7th Feb 20243:00 pmRNSTransaction in Own Shares
7th Feb 20249:30 amRNSTransaction in Own Shares
6th Feb 20249:15 amRNSTransaction in Own Shares
5th Feb 202412:30 pmRNSTransaction in Own Shares
2nd Feb 20249:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.